FENC
NASDAQ · Biotechnology
Fennec Pharmaceuticals Inc
$10.83
+0.23 (+2.12%)
Open$10.46
Previous Close$10.61
Day High$10.86
Day Low$10.07
52W High$13.25
52W Low$5.65
Volume—
Avg Volume158.5K
Market Cap372.41M
P/E Ratio—
EPS$-0.12
SectorBiotechnology
Analyst Ratings
Strong Buy
12 analysts
Price Target
+175.2% upside
Current
$10.83
$10.83
Target
$29.80
$29.80
$21.84
$29.80 avg
$37.23
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 55.15M | 74.30M | 77.18M |
| Net Income | -12,033,713 | -6,101,542 | -7,191,772 |
| Profit Margin | -21.8% | -8.2% | -9.3% |
| EBITDA | -10,258,131 | -9,610,170 | -10,191,915 |
| Free Cash Flow | — | -4,689,819 | -4,353,916 |
| Rev Growth | +207.2% | -7.2% | -5.1% |
| Debt/Equity | — | 0.51 | 0.45 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $266.28 | +0.73% | 74.3 | 468.50B |
| AMGN | Amgen Inc | $418.13 | +0.85% | 25.1 | 219.78B |
| GILD | Gilead Sciences Inc | $152.21 | +0.85% | — | 185.02B |
| VRTX | Vertex Pharmaceuticals Inc | $527.67 | +0.28% | 30.5 | 134.17B |
| REGN | Regeneron Pharmaceuticals | $752.25 | -4.54% | 18.8 | 81.31B |
| ALNY | Alnylam Pharmaceuticals Inc | $255.36 | -0.23% | 41.4 | 33.44B |